Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T13:20:48.071Z.
Calculation as of: 2026-10-06T13:20:48.071Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 02ce069849a8b6c2497016b8e0f638b4032f564ead3f461087c544bc36e3ba6b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
ASP Isotopes Inc. Common Stock
Market Cap
$368.90M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$304.38M
EBITDA Yield
10.90%
TTM Avg
9.24%
3Y Avg
10.57%
5Y Avg
20.58%
Market Cap
$293.67M
EBITDA Yield
17.50%
TTM Avg
10.89%
3Y Avg
7.56%
5Y Avg
9.96%
Market Cap
$468.98M
EBITDA Yield
N/A
TTM Avg
2.63%
3Y Avg
91.56%
5Y Avg
74.77%
Market Cap
$219.39M
EBITDA Yield
9.09%
TTM Avg
11.20%
3Y Avg
13.87%
5Y Avg
16.37%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ASP Isotopes Inc. Common Stock (ASPI) | $368.90M | N/A | N/A | N/A | N/A |
| Blue Moon Metals Inc. (BMM)vs › | $404.82M | N/A | N/A | N/A | N/A |
| Gevo, Inc. (GEVO)vs › | $314.00M | N/A | 2.89% | 2.89% | 2.89% |
| Friedman Industries, Incorporated (FRD)vs › | $304.38M | 10.90% | 9.24% | 10.57% | 20.58% |
| Alto Ingredients, Inc. (ALTO)vs › | $293.67M | 17.50% | 10.89% | 7.56% | 9.96% |
| Algoma Steel Group Inc. (ASTL)vs › | $468.98M | N/A | 2.63% | 91.56% | 74.77% |
| Hudson Technologies, Inc. (HDSN)vs › | $219.39M | 9.09% | 11.20% | 13.87% | 16.37% |
| Hongli Group Inc. (HLP)vs › | $184.60M | N/A | N/A | N/A | N/A |
| REalloys Inc. (ALOY)vs › | $553.35M | N/A | N/A | N/A | N/A |
| Lithium Americas Corp. (LAC)vs › | $569.36M | N/A | 21.03% | 21.25% | 21.25% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
